Regeneron's BCMAxCD3 Bispecific Antibody (REGN5458) Shows Deep and Durable Responses in Patients with Heavily-pretreated Multiple Myeloma in Phase 1

Press/Media

Period	7 Dec 2020

Media coverage

Title	Regeneron's BCMAxCD3 Bispecific Antibody (REGN5458) Shows Deep and Durable Responses in Patients with Heavily-pretreated Multiple Myeloma in Phase 1
Media name/outlet	BioSpace
Country/Territory	United States
Date	7/12/20
URL	https://www.biospace.com/article/releases/regeneron-s-bcmaxcd3-bispecific-antibody-regn5458-shows-deep-and-durable-responses-in-patients-with-heavily-pretreated-multiple-myeloma-in-phase-1/?s=86
Persons	Deepu Madduri